Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Optinose Inc (NQ: OPTN )

4.450 USD +0.340 (+8.27%)
Official Closing Price Updated: 7:27 PM EST, Jan 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Optinose Inc

< Previous 1 2 3 4 5 6 7 8 Next >
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs
It was an event-filled one for biotech stocks, with the release of a slew of earnings, presentations of clinical trial results and ... 
Tags ALBO GERN EVOK
From Benzinga
Optinose to Report Fourth Quarter 2018 Financial Results and Corporate Updates on March 6, 2019
Conference Call and Webcast Scheduled for Wednesday, March 6 at 8:00 a.m. Eastern Time 
From GlobeNewswire News Releases
EQWS's Underlying Holdings Imply 22% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Optinose Announces Issuance of Four Additional U.S. Patents Covering XHANCE
XHANCE Now Covered by 13 Orange Book-Listed Patents 
From GlobeNewswire News Releases
Optinose to Highlight Data at the 2019 AAAAI Annual Meeting in San Francisco
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will present clinical and health economic... 
From GlobeNewswire News Releases
Optinose Announces License Agreement
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists, today announced... 
From GlobeNewswire News Releases
Sosei Heptares Announces Medicxi to Invest Up To €40 Million in New Collaboration Based on its Orexin Agonist Program
Two newly created asset-centric companies, Orexia Limited and Inexia Limited, to develop novel therapies for neurological diseases 
From PR Newswire
Look Under The Hood: IBB Has 32% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
50 Biggest Movers From Monday
Gainers Lincoln Educational Services Corporation (NASDAQ: LINC) shares climbed 45.45 percent to close at $3.20 on Monday. China ... 
Tags ADAP MRKR Movers From Monday
From Benzinga
33 Stocks Moving In Monday's Mid-Day Session
Gainers vTv Therapeutics Inc. (NASDAQ: VTVT) shares surged 36.6 percent to $3.10 after closing up 120 percent last Friday after ... 
Tags Movers & Shakers Markets KOD
From Benzinga
The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags APLS CKPT SNOA
From Benzinga
The Math Shows PBSM Can Go To $33
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags RSLS CDTX OPTN
From Benzinga
The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas
Here's a roundup of top developments in the biotech space over the last 24 hours. No biotech stocks hit 52-week highs ... 
Tags CMRX VBLT Market News
From Benzinga
45 Biggest Movers From Yesterday
Gainers Biocept, Inc. (NASDAQ: BIOC) shares jumped 66.28 percent to close at $1.14 on Tuesday after the company entered a ... 
Tags ACIU CGIX Trading Ideas
From Benzinga
The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen
Here's a roundup of top developments in the biotech space over the last 24 hours. No biotech stock hit 52-week high in ... 
Tags Benzinga UMRX News
From Benzinga
Investor Expectations to Drive Momentum within eBay, Pulse Biosciences, Evolus, Weibo, OptiNose, and The Descartes Systems Group — Discovering Underlying Factors of Influence
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of eBay Inc. (NASDAQ:EBAY),... 
From GlobeNewswire News Releases
Optinose Announces Update to License Agreement with Avanir Pharmaceuticals for ONZETRA XSAIL
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company received written notice from Avanir... 
From GlobeNewswire News Releases
Optinose Announces First Patient Enrolled in Clinical Trial of XHANCE for Chronic Sinusitis
Company also announces first patient enrolled in clinical trial of XHANCE for treatment of nasal polyps in pediatric patients 
From GlobeNewswire News Releases
Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will... 
From GlobeNewswire News Releases
52 Biggest Movers From Friday
Gainers Borqs Technologies, Inc (NASDAQ: BRQS) shares gained 122.66 percent to close at $5.70 on Friday. Tel-Instrument ... 
Tags UXIN CASI Pre/Market Outlook
From Benzinga
38 Stocks Moving In Friday's Mid-Day Session
Gainers Determine, Inc. (NASDAQ: DTRM) shares jumped 78.7 percent to $0.84. Tel-Instrument Electronics Corp. (NYSE: TIK) shares ... 
Tags UTI AVAV SFM
From Benzinga
The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags VCEL Offerings Biotech
From Benzinga
The Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags AQST DRRX CTIC
From Benzinga
Analysts Expect EQWS Will Reach $53
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
OptiNose, Inc. (OPTN) Q3 2018 Earnings Conference Call Transcript
OPTN earnings call for the period ending September 30, 2018. 
Tags OPTN Market News
From Motley Fool
The Daily Biotech Pulse: Viking's Fatty Liver And Cholesterol Drug, Cyclacel Loss Narrows, Eton's Debut
Here's a roundup of top developments in the biotech space over the last 24 hours. None of the Nasdaq-listed biotech stocks hit ... 
Tags CYCC AERI CUR
From Benzinga
Optinose Reports Third Quarter 2018 Financial Results and Recent Operational Highlights
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported financial results for the quarter ended September 30,... 
From GlobeNewswire News Releases
Short Interest Makes 19.6% Move For OPTN
The most recent short interest data has been released for the 10/31/2018 settlement date, which shows a 1,079,926 share increase in total short interest for OptiNose Inc (OPTN), to 6,588,652, an... 
Tags Stocks
From Market News Video
The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs
Earnings and U.S. midterm polls continued to positively influence biotech stocks, with the sector notching gains for the second ... 
Tags FCSC TBPH VAPO
From Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.